Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Not applicableActive Not RecruitingNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Post-approval studies (Phase 4)Looking for participantsNCT06195228
What this trial is testing

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Who this might be right for
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University 800
Not applicableStudy completedNCT05332821
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 1,244
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Ended earlyNCT00671645
What this trial is testing

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Who this might be right for
Rectal Cancer
Austrian Breast & Colorectal Cancer Study Group 8
Early research (Phase 1)Study completedNCT04959981
What this trial is testing

Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Erasca, Inc. 24
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848439
What this trial is testing

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

Who this might be right for
Mouth NeoplasmsNeoadjuvant TherapyImmunotherapy+1 more
Jiangsu Cancer Institute & Hospital 26
Testing effectiveness (Phase 2)Looking for participantsNCT05048901
What this trial is testing

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors,Gastroenteropancreatic
National Health Research Institutes, Taiwan 49
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Testing effectiveness (Phase 2)Study completedNCT02645149
What this trial is testing

Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 216
Not applicableStudy completedNCT02613962
What this trial is testing

Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling

Who this might be right for
Relapsed or Refractory Pediatric Tumor
Gustave Roussy, Cancer Campus, Grand Paris 791
Not applicableStudy completedNCT02639871
What this trial is testing

Dynamic Neuroimaging Biomarkers in Huntington's Disease

Who this might be right for
Brain Neuroimaging Biomarkers in Huntington Disease
Assistance Publique - Hôpitaux de Paris 81
Not applicableStudy completedNCT00896766
What this trial is testing

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 150
Testing effectiveness (Phase 2)Study completedNCT01306045
What this trial is testing

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Small Cell LungCarcinoma, Thymic
National Cancer Institute (NCI) 647
Not applicableStudy completedNCT06376773
What this trial is testing

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.

Who this might be right for
Advanced Gastric CancerNeoadjuvant TherapyMulti-omics Analysis
Fujian Medical University 234
Not applicableLooking for participantsNCT06881446
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without TACE for Advanced HCC with Vascular Invasions

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,200
Large-scale testing (Phase 3)Active Not RecruitingNCT03049189
What this trial is testing

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 324
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Load More Results